Who we are

The Canadian Clinical Trials Coordinating Centre was created to strengthen the Canadian clinical trials environment  and promote Canada as a leading destination for clinical trials globally.

CCTCC's initiatives, aimed at introducing operational efficiencies, are a combination of recommendations from a 2012 action plan to attract clinical trials to Canada and more recent needs of Canadian clinical trials field.  

More details about our initiatives are available here

More information about "To Your Health and Prosperity – An Action Plan to Help Attract More Clinical Trials to Canada", which was developed through extensive stakeholder consultation, is available here.

The CCTCC is a unique collaboration between government - Canadian Institutes of Health Research (CIHR), industry Innovative Medicines Canada, and healthcare institutions HealthCareCAN.

What are clinical trials and why are they important?

Clinical trials involve testing new therapies with patients. They are a critical step toward bringing new medicines, effective vaccines, and innovative medical devices safely to market. They can result in better medical treatments, better quality of life, cost savings to Canada’s health system, new jobs, and revenue for the Canadian economy. Most importantly, clinical trials have the potential to relieve pain and suffering, and to reverse or halt the effects of disease or disability for Canadian patients.


Quick Facts

  • The Canadian Clinical Trials Asset Map (CCTAM) is a unique, robust, searchable web-based database designed to showcase Canada's clinical research strengths. It is the first pan-Canadian research inventory with an integrated map-based search function that lists Canadian investigators, clinical research sites, hospitals, institutions, research ethics boards and other clinical research resources available across the country.

    Its purpose is to:

    • Showcase the tremendous assets available in Canada to conduct clinical trials
    • Provide a comprehensive database of all Canadian clinical research assets; better enabling sponsors of clinical trials to identify clinical research sites and investigators.
    • Allow for easy navigation of the Canadian clinical trials landscape and expedite study feasibility analysis for trial sponsors
    • Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace. 




    At the Canadian Institutes of Health Research (CIHR), we know that research has the power to change lives. As Canada's health research investment agency, we collaborate with partners and researchers to support the discoveries and innovations that improve our health and strengthen our health care system.  

  • Strategy for Patient-Oriented Research (SPOR) is a national coalition of federal, provincial and territorial partners (patients and caregivers, researchers, health practitioners, policy makers, provincial/territorial health authorities, academic institutions, charities, and private sector) dedicated to the integration of research into care.

    The objective of SPOR is to foster evidence-informed health care by bringing innovative diagnostic and therapeutic approaches to the point of care, so as to ensure greater quality, accountability, and accessibility of care.

  • Innovative Medicines Canada (formerly known as Rx&D) is the association of leading research-based pharmaceutical companies dedicated to improving the health of all Canadians through the discovery, development, and delivery of new medicines and vaccines.

    As the national voice of research-based pharmaceutical companies, Innovative Medicines Canada advocates for policies that enable the discovery, development, and commercialization of innovative medicines and vaccines that will improve the lives of all Canadians. They support their members' commitment to being value partners in the Canadian healthcare system.

  • HealthCare​CAN​ is the national voice of healthcare organizations in Canada. They foster informed and continuous, rsults oriented discovery and innovation across the continuum of healthcare. They act with others to enhance the health of all Canadians; to build the capability for high quality care; and to help ensure value for money in publicly financed, healthcare programs.